ATE106743T1 - Fgf enthaltende stabilisierte zubereitungen. - Google Patents

Fgf enthaltende stabilisierte zubereitungen.

Info

Publication number
ATE106743T1
ATE106743T1 AT90904852T AT90904852T ATE106743T1 AT E106743 T1 ATE106743 T1 AT E106743T1 AT 90904852 T AT90904852 T AT 90904852T AT 90904852 T AT90904852 T AT 90904852T AT E106743 T1 ATE106743 T1 AT E106743T1
Authority
AT
Austria
Prior art keywords
tissular
fgfs
applications
preparations containing
fgf
Prior art date
Application number
AT90904852T
Other languages
English (en)
Inventor
Denis Barritault
Jacqueline Jozefonvicz
Faouzi Slaoui
Michele Tardieu
Jean-Pierre Caruelle
Jose Courty
Original Assignee
Therapeutiques Substitutives
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9379523&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE106743(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Therapeutiques Substitutives filed Critical Therapeutiques Substitutives
Application granted granted Critical
Publication of ATE106743T1 publication Critical patent/ATE106743T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT90904852T 1989-03-09 1990-03-09 Fgf enthaltende stabilisierte zubereitungen. ATE106743T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903086A FR2644066B1 (fr) 1989-03-09 1989-03-09 Compositions stabilisees comprenant des fgfs, leur procede d'obtention et leurs applications therapeutiques, chirurgicales et cosmetologiques

Publications (1)

Publication Number Publication Date
ATE106743T1 true ATE106743T1 (de) 1994-06-15

Family

ID=9379523

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90904852T ATE106743T1 (de) 1989-03-09 1990-03-09 Fgf enthaltende stabilisierte zubereitungen.

Country Status (10)

Country Link
EP (1) EP0462194B1 (de)
JP (1) JP3236916B2 (de)
AT (1) ATE106743T1 (de)
AU (1) AU5283890A (de)
CA (1) CA2048638C (de)
DE (1) DE69009748T2 (de)
DK (1) DK0462194T3 (de)
ES (1) ES2057544T3 (de)
FR (1) FR2644066B1 (de)
WO (1) WO1990010456A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202311A (en) * 1988-08-19 1993-04-13 Children's Medical Center Corporation Stabilized fgf composition
US5482929A (en) * 1991-12-26 1996-01-09 Kaken Pharmaceutical Co., Ltd. Composition of stabilized fibroblast growth factor
FR2718024B1 (fr) * 1994-03-30 1996-06-21 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement de l'inflammation.
FR2718025B1 (fr) * 1994-03-30 1996-06-21 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement des lésions du système nerveux.
FR2718026B1 (fr) * 1994-03-30 1997-01-17 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement des muscles.
FR2718023B1 (fr) * 1994-03-30 1996-08-14 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement de lésions du tractus digestif.
FR2772382B1 (fr) * 1997-12-11 2000-03-03 Solutions Derives de dextrane, leur procede de preparation et leurs applications comme medicaments a action biologique specifique
FR2781485B1 (fr) 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
FR2781375A1 (fr) * 1998-07-21 2000-01-28 Denis Barritault Composition anti-fibrotique contenant des polymeres ou biopolymeres et leurs utilisations
DE69936212T2 (de) * 1998-09-04 2008-01-24 Scios Inc., Sunnyvale Hydrogelzusammensetzungen mit kontrollierter Freigabe für die Verabreichung von Wachstumsfaktoren
FR2794649B1 (fr) * 1999-06-11 2003-04-11 Solutions Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
FR2794976B1 (fr) * 1999-06-16 2004-05-07 Solutions Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
US8846003B2 (en) 2008-03-27 2014-09-30 Symic Biomedical, Inc. Collagen-binding synthetic peptidoglycans, preparation, and methods of use
EP2714718B1 (de) 2011-05-24 2017-01-11 Symic IP, LLC Hyaluronsäurebindende synthetische peptidoglycane, ihre herstellung und verfahren zu ihrer verwendung
BR112015022917A2 (pt) 2013-03-15 2017-07-18 Symic Biomedical Inc peptidoglicanos sintéticos componentes da matriz extracelular
US10772931B2 (en) 2014-04-25 2020-09-15 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
US10792106B2 (en) 2016-10-28 2020-10-06 Covidien Lp System for calibrating an electromagnetic navigation system
EP3648774A4 (de) 2017-07-07 2021-04-21 Symic IP, LLC Synthetische biokonjugate
US11596399B2 (en) 2021-06-23 2023-03-07 Covidien Lp Anvil buttress attachment for surgical stapling apparatus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222413A (en) * 1986-11-05 1991-06-25 Ethicon Inc Compositions containing a polypeptide growth factor and a water-soluble cellulose polymer stabiliser

Also Published As

Publication number Publication date
FR2644066B1 (fr) 1994-05-13
ES2057544T3 (es) 1994-10-16
DE69009748D1 (de) 1994-07-14
CA2048638C (en) 2002-06-11
AU5283890A (en) 1990-10-09
DE69009748T2 (de) 1994-09-22
FR2644066A1 (fr) 1990-09-14
EP0462194B1 (de) 1994-06-08
JP3236916B2 (ja) 2001-12-10
EP0462194A1 (de) 1991-12-27
CA2048638A1 (en) 1990-09-10
WO1990010456A1 (fr) 1990-09-20
JPH04505756A (ja) 1992-10-08
DK0462194T3 (da) 1994-09-19

Similar Documents

Publication Publication Date Title
DE69009748D1 (de) Fgf enthaltende stabilisierte zubereitungen.
DE3874813D1 (de) Zusammensetzung zur behandlung der haut.
EP0202298A4 (de) Heilmittel für wunden.
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
FI880845A0 (fi) bFGF:n muteiinia koodaava DNA, mainittua DNA:ta sisältävä transformoitu bakteeri ja menetelmä muteiinin tuottamiseksi
FI883055A7 (fi) Deodoroiva ja antimikrobinen koostumus käytettäväksi kosmeettisissa tai paikallisesti käytettävissä valmisteissa.
GR3025596T3 (en) Compositions and methods for identifying biologically active molecules.
ATE87319T1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
DE69025920D1 (de) Glykosaminoglykan-modifiertes Protein, Verfahren zu dessen Herstellung und pharmazeutische Zubereitungen, die es enthalten
ATE96329T1 (de) Topisch anwendbare pharmazeutische zubereitung.
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
NO20004282D0 (no) Matriksproteinpreparater for sÕrheling
DE69513324D1 (de) L-Lysyl-Glycyl-L-Histidin und entsprechende pharmazeutische Zusammensetzungen zur Wundheilung
ATE363909T1 (de) Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten
ATE345809T1 (de) Arzneimittelzusammensetzung enthaltend tcf-ii
DE59304087D1 (de) Placentaextrakt und Verfahren zu seiner Herstellung
DE69814691D1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
ES2149347T3 (es) Composiciones farmaceuticas de verotoxinas y tratamientos medicos con las mismas.
ES8801624A1 (es) Procedimiento para preparar disulfuros heterociclicos
DE69113049D1 (de) Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
DE69008282D1 (de) Kaffeesäure-Derivate, deren Verwendung für medizinische Behandlungen und diese enthaltende pharmazeutische Zusammensetzungen.
UA5743C2 (uk) Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання
UA10281C2 (uk) Спосіб отримання речовини для лікування захворювань підшлункової залози

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee